Definium Therapeutics Inc. Common Shares vs Navitas Semiconductor Corporation Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.4 (market cap $4.59B), while Navitas Semiconductor Corporation Common Stock trades at $11.3 (market cap $2.87B). The key difference: Definium Therapeutics Inc. Common Shares is the larger of the two by market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Navitas Semiconductor Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Navitas Semiconductor Corporation Common Stock for 0 Days on average.
| DFTX | NVTS | |
|---|---|---|
Market Cap | $4.59B | $2.87B |
Volume | 2,103,937 | 13,752,519 |
Sector | Health | Technology |
52-Week High | $48.45 | $31.79 |
52-Week Low | $10.68 | $7.14 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $2.32B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Navitas Semiconductor designs and markets gallium nitride and silicon carbide power semiconductors. Its products are used in power conversion and charging for data centers, energy infrastructure, and industrial applications.
Read more on NVTS →